181 related articles for article (PubMed ID: 26033596)
1. Simulation of Chemoperfusion Treatment for Abdominal Carcinomatosis.
Bespalov VG; Belyaeva OA; Kireeva GS; Senchik KY; Stukov AN; Belyaev AM
Bull Exp Biol Med; 2015 May; 159(1):81-4. PubMed ID: 26033596
[TBL] [Abstract][Full Text] [Related]
2. [Experimental technology of chemoperfusion treatment for abdominal carcinomatosis in ovarian cancer].
Beliaeva OA; Bespalov VG; Senchik KIu; Kireeva GS; Stukov AN; Aristova VA; Ivantsov AO; Vyshinskaia EA; Maĭdin MA; Semënov AL; Aleksandrov VA; Beliaev AM
Vopr Onkol; 2014; 60(1):71-9. PubMed ID: 24772620
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and pharmacodynamics of cisplatin after intraoperative hyperthermic intraperitoneal chemoperfusion (HIPEC).
Zeamari S; Floot B; van der Vange N; Stewart FA
Anticancer Res; 2003; 23(2B):1643-8. PubMed ID: 12820435
[TBL] [Abstract][Full Text] [Related]
4. [Intraoperative intraperitoneal chemoperfusion treatment with cisplatin and dioxadet on a model of peritoneal carcinomatosis in ovarian cancer: safety and efficacy evaluation].
Bespalov VG; Kireeva GS; Belyaeva OA; Senchik KY; Stukov AN; Gafton GI; Soloviev LA; Vasilchenko MV; Guseinov KD; Alexeev VV; Belyaev AM
Vopr Onkol; 2015; 61(4):647-52. PubMed ID: 26571838
[TBL] [Abstract][Full Text] [Related]
5. [Antitumor effect of dioxadet in intraperitoneal chemoperfusion treatment for advanced ovarian cancer in experimental setting].
Bespalov VG; Beliaeva OA; Kireeva GS; Senchik KIu; Stukov AN; Aristova VA; Vyshinskaia EA; Kon'kov SA; Krylova IA; Semënov AL; Maĭdin MA; Aleksandrov VA; Beliaev AM
Vopr Onkol; 2014; 60(2):72-9. PubMed ID: 24919266
[TBL] [Abstract][Full Text] [Related]
6. Histological response of peritoneal carcinomatosis after hyperthermic intraperitoneal chemoperfusion (HIPEC) in experimental investigations.
Pelz JO; Doerfer J; Dimmler A; Hohenberger W; Meyer T
BMC Cancer; 2006 Jun; 6():162. PubMed ID: 16792796
[TBL] [Abstract][Full Text] [Related]
7. Both heat and new chemotherapeutic drug dioxadet in hyperthermic intraperitoneal chemoperfusion improved survival in rat ovarian cancer model.
Bespalov VG; Kireeva GS; Belyaeva OA; Kalinin OE; Senchik KY; Stukov AN; Gafton GI; Guseynov KD; Belyaev AM
J Surg Oncol; 2016 Mar; 113(4):438-42. PubMed ID: 26710749
[TBL] [Abstract][Full Text] [Related]
8. [Intraperitoneal hyperthermic perfusion chemotherapy in recurrent ovarian cancer].
Wydra D; Emerich J
Ginekol Pol; 2002 Nov; 73(11):1044-7. PubMed ID: 12722397
[TBL] [Abstract][Full Text] [Related]
9. Experimental study of antitumour activity and effects on leukocyte count of intraperitoneal administration and hyperthermic intraperitoneal chemoperfusion (HIPEC) with dioxadet in a rat model of ovarian cancer.
Bespalov VG; Kireeva GS; Belyaeva OA; Senchik KY; Stukov AN; Maydin MA; Semenov AL; Gafton GI; Guseynov KD; Belyaev AM
J Chemother; 2016 Jun; 28(3):203-9. PubMed ID: 26027427
[TBL] [Abstract][Full Text] [Related]
10. Comparative efficacy evaluation of catheter intraperitoneal chemotherapy, normothermic and hyperthermic chemoperfusion in a rat model of ascitic ovarian cancer.
Bespalov VG; Alvovsky IK; Tochilnikov GV; Stukov AN; Vyshinskaya EA; Semenov AL; Vasilyeva IN; Belyaeva OA; Kireeva GS; Senchik KY; Zhilinskaya NT; Von JD; Krasilnikova LA; Alexandrov VA; Khromov-Borisov NN; Baranenko DA; Belyaev AM
Int J Hyperthermia; 2018 Aug; 34(5):545-550. PubMed ID: 28893108
[TBL] [Abstract][Full Text] [Related]
11. Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery for peritoneal carcinomatosis in an experimental model.
Klaver YL; Hendriks T; Lomme RM; Rutten HJ; Bleichrodt RP; de Hingh IH
Br J Surg; 2010 Dec; 97(12):1874-80. PubMed ID: 20806291
[TBL] [Abstract][Full Text] [Related]
12. A new survival model for hyperthermic intraperitoneal chemotherapy (HIPEC) in tumor-bearing rats in the treatment of peritoneal carcinomatosis.
Pelz JO; Doerfer J; Hohenberger W; Meyer T
BMC Cancer; 2005 May; 5():56. PubMed ID: 15924622
[TBL] [Abstract][Full Text] [Related]
13. Extensive cytoreductive surgery combined with intra-operative intraperitoneal perfusion with cisplatin under hyperthermic conditions (OVHIPEC) in patients with recurrent ovarian cancer: a feasibility pilot.
van der Vange N; van Goethem AR; Zoetmulder FA; Kaag MM; van de Vaart PJ; ten Bokkel Huinink WW; Beijnen JH
Eur J Surg Oncol; 2000 Nov; 26(7):663-8. PubMed ID: 11078613
[TBL] [Abstract][Full Text] [Related]
14. Continuous Intraoperative Intraperitoneal Hyperthermic Chemoperfusion (CIIPHCP) in the treatment of advanced stage and recurrent granulosa cell tumors. Report of two cases.
Chatzigeorgiou K; Economou S; Zafiriou G; Minopoulos G; Manolas K; Chatzigeorgiou N
Zentralbl Gynakol; 2002 Jul; 124(7):374-7. PubMed ID: 12439765
[TBL] [Abstract][Full Text] [Related]
15. A phase I trial of continuous hyperthermic peritoneal perfusion with tumor necrosis factor and cisplatin in the treatment of peritoneal carcinomatosis.
Bartlett DL; Buell JF; Libutti SK; Reed E; Lee KB; Figg WD; Venzon DJ; Alexander HR
Cancer; 1998 Sep; 83(6):1251-61. PubMed ID: 9740093
[TBL] [Abstract][Full Text] [Related]
16. Normothermic and Hyperthermic Intraperitoneal Chemoperfusions with Cisplatin to Treat Advanced Ovarian Cancer in Experimental Settings.
Kireeva GS; Bespalov VG; Belyaeva OA; Senchik KY; Stukov AN; Gafton GI; Guseynov KD; Belyaev AM
Pathol Oncol Res; 2017 Apr; 23(2):459-460. PubMed ID: 28116562
[No Abstract] [Full Text] [Related]
17. Intraperitoneal hyperthermic chemotherapy in ovarian cancer.
Gori J; Castaño R; Toziano M; Häbich D; Staringer J; De Quirós DG; Felci N
Int J Gynecol Cancer; 2005; 15(2):233-9. PubMed ID: 15823105
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of hyperthermic intraperitoneal chemoperfusion with high-dose oxaliplatin in patients with peritoneal carcinomatosis.
Ceelen WP; Peeters M; Houtmeyers P; Breusegem C; De Somer F; Pattyn P
Ann Surg Oncol; 2008 Feb; 15(2):535-41. PubMed ID: 17960463
[TBL] [Abstract][Full Text] [Related]
19. Patient selection for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy, and role of laparoscopy in diagnosis, staging, and treatment.
Valle M; Federici O; Garofalo A
Surg Oncol Clin N Am; 2012 Oct; 21(4):515-31. PubMed ID: 23021713
[TBL] [Abstract][Full Text] [Related]
20. Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer.
Di Giorgio A; Naticchioni E; Biacchi D; Sibio S; Accarpio F; Rocco M; Tarquini S; Di Seri M; Ciardi A; Montruccoli D; Sammartino P
Cancer; 2008 Jul; 113(2):315-25. PubMed ID: 18473354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
